The shift towards a complex global supply chain incorporating many suppliers and service providers is driving adoption of modern analytical methods to ensure quality.
US based healthcare distributer, Cardinal Health, has announced the $470m acquisition of privately held healthcare distribution business Zuellig Pharma China, known locally as Yong Yu.
Last week everything from co-processed excipients to Viagra-stuffed teddies were discussed at AAPS 2010. Now, with the show having finished, we present our personal take on the event.
Parexel has collaborated with Stora Enso to add an integrated temperature recording system which can save up to 48 hours compared to traditional cold chain.
M&A can help revitalize firms but failure to properly integrate the companies can create an inefficient, demoralized business. In this article, Viq Pervaaz, senior vice president at Aon Consulting, takes a look at M&A processes, pitfalls and keys...
KryoTrans International claims its developmental KT1500 reusable container for drug shipments will be first passive temperature-controlled unit capable of accepting pallets and a boon for CROs in the globalised trial sector.
eBizNET has entered into a strategic relationship with CDC Software, which is expected to accelerate the deployment of its SaaS supply chain systems in emerging, high growth markets.
MLawGroup and WS Partners are collaborating to offer pharma and biotech advisory services, including help in preparing and negotiating agreements with CROs and CMOs.
Charles River Laboratories’ (CRL) Shanghai preclinical test facility GLP certified by Belgian authorities under the OECD’s mutual acceptance of data framework.
Rising use of biologics and a tax initiative will drive the streamlining of Indian supply chains, helping companies to deliver drugs at affordable prices, according to PwC.
The drug industry will gain new options for sterile contract development and manufacturing in the near future with DPT Laboratories, NextPharma and Vetter each working on new dedicated units.
Eli Lilly has taken an expansive approach to outsourcing, adding an agreement with Thermo Fisher to its raft of deals, and this strategy is visualised in an interactive timeline from Outsourcing-Pharma.
BioStorage Technologies has allied with Biomatrica to offer clients the option to store biological samples at room temperature, which reduces costs and energy use while maintaining stability.
The shipping requirements of drugs means the TSA’s new law poses unique problems to the pharma industry, according to DHL, but experience of tight regulations should help companies achieve compliance.
Indian CMO Bilcare says need to test new drugs in diverse patient groups drove expansion of its cold chain clinical trial supply packaging and storage facility in Crickhowell, Wales.
Fujifilm has introduced an anti-counterfeiting label, called ForgeGuard, which it claims is the first product with full colour images and text that can be checked using a viewing device.
BioClinica Optimizer has launched to allow users to simulate and optimise their clinical trials, providing information to identify potential supply shortages or excesses and study delays.
In the economic downturn biotechs have cut back on outsourcing to Asia and opted to use the US instead because they lack the resources to manage overseas relationships, according to a SOCMA representative.
US Pharma firms can benefit from the sourcing, storage and distribution efficiencies offered by comparator drug sourcing and distribution specialist Pharmarama says managing director Rosemary Bensley.
Almac Clinical Services says novel temperature monitoring system speeds shipping and cuts quarantine times by allowing authorised personnel to make decisions on trial supplies at clinical sites 24/7.
The US FDA says its new screening system will expedite the importation of genuine drugs and help inspectors focus their efforts on “high risk” products.
BioStorage Technologies has come up with a novel solution to cold-chain transport, launching a mobile biorepository that is capable of transporting samples across the continental US on a single tank of fuel.
A MEP has questioned the EC’s estimate that 20,000 API producers supply the EU, which was used to justify not having mandatory inspections, and the CEO of Hovione added that the numbers have been “dramatically misunderstood”.
World Courier has GxP compliant status for its whole distribution network, covering more than 140 offices in 50 countries, which it believes no other business in the sector has achieved on such a large scale.
The recent wave of M&A will lead to manufacturing over-capacity at pharma companies but only a small number of these sites will be sold to CMOs, in part because of the facilities’ suboptimal locations, according to a report.
Welsh contract services firm Penn Pharmaceuticals has reorganised its transport and delivery infrastructure in the first phase of a £12m (€13.3m) expansion at its facility in Tredegar.
Indian CRO Siro Clinpharma has ramped up clinical trial manufacturing capacity at its facility in Mumbai in response to growing demand from pharma and biotech firms.
World Courier has opened investigational drug storage facilities in South Africa and Australia, a move it says is in response to growth in the regions' clinical trials markets.
We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies.
DHL is investing $15m (€10.2m) in its logistics infrastructure in Asia, increasing capacity in India to meet demand for supply chain services that are in compliance with stricter regulatory and quality requirements.
Having filed for bankruptcy in December Introgen Therapeutics has sold its assets, including management and technical team, to Vivante, a company that formed last week as a contract manufacturing organisation (CMO).
BioClinica is continuing to acquire companies in the wake of the collapse of its etrials bid, buying software and services provider Tourtellotte Solutions just over two weeks after its last takeover.
Quintiles believes there is a “dire need” for trial sites that can raise standards and reduce inefficiencies in the clinical research process and is expanding its Prime Site programme to meet this demand.
Canadian group Clinical Logistics (CL) and US analysis specialist Gentris have teamed up to develop a dedicated low temperature storage service for clinical cell and DNA samples collected during drug trials.
Biotechs that partner or outsource in emerging markets are better equipped to innovate and prosper, according to research that warns “if you are not in Shanghai, Mumbai, or Dubai, watch out".
Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...
